Ocular Therapeutix (OCUL) Profit After Tax (2016 - 2025)

Historic Profit After Tax for Ocular Therapeutix (OCUL) over the last 13 years, with Q4 2025 value amounting to -$64.7 million.

  • Ocular Therapeutix's Profit After Tax fell 3361.58% to -$64.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$265.9 million, marking a year-over-year decrease of 3743.19%. This contributed to the annual value of -$265.9 million for FY2025, which is 3743.19% down from last year.
  • Per Ocular Therapeutix's latest filing, its Profit After Tax stood at -$64.7 million for Q4 2025, which was down 3361.58% from -$69.4 million recorded in Q3 2025.
  • Ocular Therapeutix's 5-year Profit After Tax high stood at $3.1 million for Q1 2021, and its period low was -$69.4 million during Q3 2025.
  • Over the past 5 years, Ocular Therapeutix's median Profit After Tax value was -$26.7 million (recorded in 2022), while the average stood at -$30.9 million.
  • As far as peak fluctuations go, Ocular Therapeutix's Profit After Tax surged by 12224.55% in 2021, and later tumbled by 697228.68% in 2024.
  • Quarter analysis of 5 years shows Ocular Therapeutix's Profit After Tax stood at -$3.8 million in 2021, then crashed by 303.69% to -$15.5 million in 2022, then plummeted by 88.01% to -$29.2 million in 2023, then tumbled by 65.6% to -$48.4 million in 2024, then tumbled by 33.62% to -$64.7 million in 2025.
  • Its Profit After Tax was -$64.7 million in Q4 2025, compared to -$69.4 million in Q3 2025 and -$67.8 million in Q2 2025.